+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

NASH Treatment & Therapeutics Market Report 2023-2033 - Product Thumbnail Image

NASH Treatment & Therapeutics Market Report 2023-2033

  • Report
  • July 2023
  • 224 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2024 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Erythropoietin (EPO) Global Market Report 2024 - Product Thumbnail Image

Erythropoietin (EPO) Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Alcoholic Hepatitis Treatment Global Market Report 2024 - Product Thumbnail Image

Alcoholic Hepatitis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Late Stage Chronic Kidney Disease Drugs Global Market Report 2024 - Product Thumbnail Image

Late Stage Chronic Kidney Disease Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Hepatitis C Global Market Report 2024 - Product Thumbnail Image

Hepatitis C Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Fatty Liver Treatment Global Market Report 2024 - Product Thumbnail Image

Fatty Liver Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Liver Diseases Therapeutics Global Market Report 2024 - Product Thumbnail Image

Liver Diseases Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Viral Hepatitis Global Market Report 2024 - Product Thumbnail Image

Viral Hepatitis Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Hepatitis B Virus (HBV) Global Market Report 2024 - Product Thumbnail Image

Hepatitis B Virus (HBV) Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Hepatorenal Syndrome Treatment Global Market Report 2024 - Product Thumbnail Image

Hepatorenal Syndrome Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Nephrology Drugs Global Market Report 2024 - Product Thumbnail Image

Nephrology Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
End Stage Renal Disease (ESRD) Drug Global Market Report 2024 - Product Thumbnail Image

End Stage Renal Disease (ESRD) Drug Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Hepatitis Therapeutics Global Market Report 2024 - Product Thumbnail Image

Hepatitis Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Hepatitis Drugs Global Market Report 2024 - Product Thumbnail Image

Hepatitis Drugs Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more